{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,15]],"date-time":"2026-05-15T16:41:30Z","timestamp":1778863290333,"version":"3.51.4"},"reference-count":25,"publisher":"Wiley","issue":"1","license":[{"start":{"date-parts":[[2019,9,10]],"date-time":"2019-09-10T00:00:00Z","timestamp":1568073600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"},{"start":{"date-parts":[[2019,9,10]],"date-time":"2019-09-10T00:00:00Z","timestamp":1568073600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/doi.wiley.com\/10.1002\/tdm_license_1.1"}],"funder":[{"DOI":"10.13039\/501100003392","name":"Natural Science Foundation of Fujian Province","doi-asserted-by":"publisher","award":["2017J01169"],"award-info":[{"award-number":["2017J01169"]}],"id":[{"id":"10.13039\/501100003392","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["onlinelibrary.wiley.com"],"crossmark-restriction":true},"short-container-title":["Clinical Laboratory Analysis"],"published-print":{"date-parts":[[2020,1]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Methotrexate (MTX) is the prior drug in ectopic pregnancy (EP). However, approximately 10% of patients suffer from failure by MTX therapy. Reduced folate carrier 1 (RFC1), methylene tetrahydrofolate reductase (MTHFR), and dihydrofolate reductase (DHFR) are involved in the transport and effects of MTX in vivo. In the present study, we aim to investigate the relationship between the genetic polymorphisms of RFC1, MTHFR, and DHFR and the clinical efficacy of MTX in tubal pregnancies.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>\n                      100 patients of EP were enrolled in this study. Polymorphisms of RFC1 G80A, MTHFR C677T, and DHFR A\u2010317G were genotyped.\n                      <jats:italic>\u03b2<\/jats:italic>\n                      \u2010hCG level was detected in day 0, 4, and 7 after MTX injection. Association of MTX efficacy and genetic polymorphisms was analyzed.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      Methylene tetrahydrofolate reductase C677T was associated with MTX treatment (\n                      <jats:italic>P<\/jats:italic>\n                      \u00a0=\u00a0.017). The success rate of first MTX injection was superior in patients with harboring mutation allele of MTHFR gene than that in patients with wild\u2010type gene (\n                      <jats:italic>P<\/jats:italic>\n                      \u00a0=\u00a0.001). However, there was no significant association between the polymorphisms of RFC1 G80A, DHFR A\u2010317G, and surgical treatment (\n                      <jats:italic>P<\/jats:italic>\n                      \u00a0=\u00a0.709 and .476, respectively). In addition,\n                      <jats:italic>\u03b2<\/jats:italic>\n                      \u2010hCG level decrement was not significantly changed by MTX injection with different polymorphisms of RFC1, MTHFR, and DHFR on either day 4 (\n                      <jats:italic>P<\/jats:italic>\n                      \u00a0=\u00a0.214, 0.197 and 0.270, respectively) or day 7 (\n                      <jats:italic>P<\/jats:italic>\n                      \u00a0=\u00a0.172, .554, and .726, respectively).\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>Our results suggested that the reliable indicator was polymorphism of MTHFR C677T in failure by MTX injection.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1002\/jcla.23030","type":"journal-article","created":{"date-parts":[[2019,9,10]],"date-time":"2019-09-10T05:40:37Z","timestamp":1568094037000},"update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["Contribution of genetic polymorphism of methylene tetrahydrofolate reductase on the effect of methotrexate in ectopic pregnancy patients"],"prefix":"10.1002","volume":"34","author":[{"given":"Jie","family":"Deng","sequence":"first","affiliation":[{"name":"Department of Pharmacy Fujian Provincial Maternity and Children's Hospital Affiliated Hospital of Fujian Medical University Fuzhou China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Li","family":"Chen","sequence":"additional","affiliation":[{"name":"Department of Gynecology Fujian Provincial Maternity and Children's Hospital Affiliated Hospital of Fujian Medical University Fuzhou China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Heng","family":"Xue","sequence":"additional","affiliation":[{"name":"Laboratory Medicine Fujian Provincial Maternity and Children's Hospital Affiliated Hospital of Fujian Medical University Fuzhou China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fan\u2010Xiang","family":"Zeng","sequence":"additional","affiliation":[{"name":"Department of Pharmacy Fujian Provincial Maternity and Children's Hospital Affiliated Hospital of Fujian Medical University Fuzhou China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Pei\u2010Guang","family":"Niu","sequence":"additional","affiliation":[{"name":"Department of Pharmacy Fujian Provincial Maternity and Children's Hospital Affiliated Hospital of Fujian Medical University Fuzhou China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3383-5640","authenticated-orcid":false,"given":"Dao\u2010Hua","family":"Shi","sequence":"additional","affiliation":[{"name":"Department of Pharmacy Fujian Provincial Maternity and Children's Hospital Affiliated Hospital of Fujian Medical University Fuzhou China"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2019,9,10]]},"reference":[{"key":"e_1_2_8_2_1","doi-asserted-by":"publisher","DOI":"10.1097\/AOG.0000000000002464"},{"key":"e_1_2_8_3_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.fertnstert.2013.11.127"},{"key":"e_1_2_8_4_1","doi-asserted-by":"publisher","DOI":"10.2147\/IJN.S81201"},{"key":"e_1_2_8_5_1","doi-asserted-by":"publisher","DOI":"10.14366\/usg.17044"},{"key":"e_1_2_8_6_1","doi-asserted-by":"publisher","DOI":"10.1097\/GRF.0b013e3182510a35"},{"key":"e_1_2_8_7_1","doi-asserted-by":"publisher","DOI":"10.1097\/00006250-200304000-00028"},{"key":"e_1_2_8_8_1","first-page":"579","article-title":"The influence of genetic RFC1, MS and MTHFR polymorphisms on the risk of acute lymphoblastic leukemia relapse in children and the adverse effects of methotrexate","volume":"22","author":"Niedzielska E","year":"2013","journal-title":"Adv Clin Exp Med"},{"key":"e_1_2_8_9_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.intimp.2016.05.012"},{"key":"e_1_2_8_10_1","doi-asserted-by":"publisher","DOI":"10.1146\/annurev.nutr.19.1.91"},{"key":"e_1_2_8_11_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbagen.2016.12.014"},{"key":"e_1_2_8_12_1","doi-asserted-by":"publisher","DOI":"10.1097\/AOG.0000000000002560"},{"key":"e_1_2_8_13_1","doi-asserted-by":"publisher","DOI":"10.1111\/bcpt.12966"},{"key":"e_1_2_8_14_1","doi-asserted-by":"publisher","DOI":"10.2133\/dmpk.DMPK-12-RG-128"},{"key":"e_1_2_8_15_1","doi-asserted-by":"publisher","DOI":"10.2217\/pgs.15.145"},{"key":"e_1_2_8_16_1","doi-asserted-by":"publisher","DOI":"10.1136\/ard.2004.033399"},{"key":"e_1_2_8_17_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood.V100.10.3832"},{"key":"e_1_2_8_18_1","doi-asserted-by":"publisher","DOI":"10.1038\/tpj.2015.11"},{"key":"e_1_2_8_19_1","doi-asserted-by":"publisher","DOI":"10.1038\/ng0595-111"},{"key":"e_1_2_8_20_1","doi-asserted-by":"publisher","DOI":"10.1038\/s41397-018-0047-z"},{"key":"e_1_2_8_21_1","doi-asserted-by":"publisher","DOI":"10.2217\/pgs-2017-0208"},{"key":"e_1_2_8_22_1","doi-asserted-by":"publisher","DOI":"10.5603\/GP.a2018.0091"},{"key":"e_1_2_8_23_1","first-page":"111","article-title":"Pharmacogenetic effects of methotrexate (Mtx) in ukrainian patients depending on the mthfr genotypes (Clinical Cases)","author":"Fedota O","year":"2018","journal-title":"Georgian Med News"},{"key":"e_1_2_8_24_1","doi-asserted-by":"publisher","DOI":"10.1042\/CS20180932"},{"key":"e_1_2_8_25_1","doi-asserted-by":"publisher","DOI":"10.2217\/pgs-2017-0153"},{"key":"e_1_2_8_26_1","first-page":"178","article-title":"Association of dihydrofolate reductase (DHFR) \u2010317AA genotype with poor response to methotrexate in patients with rheumatoid arthritis","volume":"30","author":"Milic V","year":"2012","journal-title":"Clin Exp Rheumatol"}],"container-title":["Journal of Clinical Laboratory Analysis"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1002%2Fjcla.23030","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1002\/jcla.23030","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/full-xml\/10.1002\/jcla.23030","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1002\/jcla.23030","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,13]],"date-time":"2026-04-13T12:50:17Z","timestamp":1776084617000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1002\/jcla.23030"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,9,10]]},"references-count":25,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2020,1]]}},"alternative-id":["10.1002\/jcla.23030"],"URL":"https:\/\/doi.org\/10.1002\/jcla.23030","archive":["Portico"],"relation":{},"ISSN":["0887-8013","1098-2825"],"issn-type":[{"value":"0887-8013","type":"print"},{"value":"1098-2825","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,9,10]]},"assertion":[{"value":"2019-06-28","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2019-08-13","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2019-09-10","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}],"article-number":"e23030"}}